Your search for non small cell lung cancer returned 37 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove
Drugs in the Pipeline remove

Your search for non small cell lung cancer returned 37 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Phase 2 study of ARQ 197 for non small cell lung cancer (NSCLC)

ArQule and Daiichi Sankyo announced the presentation of data from a Phase 2 trial showing encouraging overall survival (OS) results with ARQ 197 in combination with erlotinib among patients with advanced, refractory non-small cell lung cancer (NSCLC).